(Q45865952)

17 December 2017

title

Constraining the cell cycle: regulating cell division and differentiation by gene therapy (English)

1 reference

17 December 2017

0 references

1

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

17 December 2017

published in

Nature Medicine

1 reference

17 December 2017

volume

1

1 reference

17 December 2017

issue

10

1 reference

17 December 2017

page(s)

1004-1006

1 reference

17 December 2017

The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

7 January 2021

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

7 January 2021

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

7 January 2021

Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

7 January 2021

Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

7 January 2021

Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA.

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

7 January 2021

Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

7 January 2021

Cancer therapy meets p53

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

7 January 2021

Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

7 January 2021

Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

7 January 2021

An apoptotic defect in lens differentiation caused by human p53 is rescued by a mutant allele

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1004

7 January 2021

Identifiers

DOI

10.1038/NM1095-1004

1 reference

17 December 2017

Dimensions Publication ID

1048786074

0 references

1 reference

17 December 2017